Highlights:
Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fourth Quarter 2023; Raising 2024 Revenue Guidance
Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fourth Quarter 2023; Raising 2024 Revenue Guidance
LabNews Media LLC
The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They have been bestselling authors, science writers, and science journalists since 1994.More details about their writing at X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu
Similar Posts
Iran as the Political Winner: The Preliminary Ceasefire with the USA
The two-week ceasefire agreed upon on Tuesday between the USA, Israel, and Iran marks the preliminary end of an escalation that has gripped the Middle East since February 2026.
Government Failure in Winter Services – Germany in Snow Chaos 2026
A winter storm with up to 15 centimeters of new snow has plunged Germany into traffic chaos. Highways and country roads are blocked in many places, accidents are increasing, and the…
Dementia: Recognizing Symptoms and Warning Signs
Dementia is a progressive brain disease that leads to a decline in cognitive abilities. It affects memory, thinking, orientation, and the…
